Mari Mori

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects

Masahiro Kitamura, Motoki Akamatsu, Masamitsu Kawanami et al. · Journal of Bone and Mineral Research · 2015 · 136 citations · Full text

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation

Magdalena Koczkowska, Tom Callens, Alicia Gomes et al. · Genetics in Medicine · 2018 · 93 citations · Full text

Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG

Peter Witters, Shawn Tahata, Rita Barone et al. · Genetics in Medicine · 2020 · 74 citations · Full text

Biochemistry, Galactose Supplementation, Metabolism +2

The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

Aya Abu‐El‐Haija, Honey V. Reddi, Hannah Wand et al. · Genetics in Medicine · 2023 · 69 citations · Full text

Genetics, American College, Genetic Epidemiology +11

Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teeth

Mari Mori, Stephanie DeArmey, Thomas J. Weber et al. · Bone Reports · 2016 · 58 citations · Full text